James Gilson
Medical · Canton, MINPI 1821052440
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 449 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 449 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Boston Scientific$2K
- Collegium Pharmaceutical, Inc.$693
- Scilex Pharmaceuticals Inc.$488
- Nalu Medical, Inc.$414
- IBSA Pharma Inc.$384
- plus $3K from 31 others
What the payments were for
- Food & beverage$8,688100%
- Education$00%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 104 | $1,716 |
| Boston Scientific | 61 | $1,516 |
| Collegium Pharmaceutical, Inc. | 44 | $693 |
| Scilex Pharmaceuticals Inc. | 22 | $488 |
| Nalu Medical, Inc. | 11 | $414 |
| IBSA Pharma Inc. | 23 | $384 |
| Pfizer | 21 | $379 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $336 |
| Tersera Therapeutics LLC | 11 | $316 |
| Amgen(2 entities) | 18 | $242 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $188 |
| Lundbeck LLC | 6 | $156 |
| Medtronic | 6 | $149 |
| Abbott | 3 | $143 |
| Almatica Pharma LLC | 11 | $137 |
| Relievant Medsystems, Inc. | 2 | $136 |
| Nevro Corp. | 5 | $135 |
| Biohaven Pharmaceuticals, Inc. | 6 | $133 |
| Averitas Pharma Inc. | 5 | $109 |
| Vertex | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Saluda Medical Americas, Inc. | 2 | $73 |
| SPR Therapeutics, Inc | 5 | $65 |
| Biodelivery Sciences International, Inc. | 5 | $61 |
| GRT US Holding, Inc. | 6 | $58 |
| Virtus Pharmaceuticals LLC | 4 | $57 |
| USWM, LLC | 4 | $53 |
| Pacira Pharmaceuticals Incorporated | 2 | $53 |
| Si-bone, Inc. | 2 | $41 |
| Spinal Simplicity, LLC | 2 | $40 |
| Valinor Pharma, LLC | 2 | $39 |
| Fidia Pharma USA Inc. | 2 | $35 |
| Tonix Medicines, Inc. | 2 | $34 |
| Painteq LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Baudax Bio Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,688 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 268 | $37,074 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 847 | $12,347 |
| Buprenorphine | 43 | $11,230 |
| Gabapentin | 577 | $8,603 |
| Tramadol Hcl ErTramadol Hcl | 113 | $7,859 |
| Pregabalin | 234 | $7,223 |
| Xtampza ErOxycodone Myristate | 12 | $7,209 |
| OxycontinOxycodone Hcl | 14 | $6,943 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 496 | $6,651 |
| MovantikNaloxegol Oxalate | 13 | $6,585 |
| Morphine Sulfate ErMorphine Sulfate | 214 | $4,217 |
| Oxycodone Hcl | 205 | $3,664 |
| Tizanidine Hcl | 188 | $3,028 |
| Duloxetine Hcl | 139 | $2,604 |
| Lidocaine | 19 | $1,955 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $693 | $7,20912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 755 medical providers in Michigan.
Other medical in Canton
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$56K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
- John BrabantDetroit$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.